Sulfuric Acid

Sulfuric Acid

SCHEMBL127383

C=C(C)C(=O)OCCN(C)C.O=S(=O)(O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 1/20 0.47
CHRM1 known ✓ P11229 1/20 0.47
CHRM3 known ✓ P20309 1/20 0.47
THRB P10828 1/20 0.47
CHRM4 P08173 1/20 0.47
CHRM5 P08912 1/20 0.47
CHRNB2 P17787 1/20 0.47
CHRNA4 P43681 1/20 0.47
TSHR P16473 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.40
DNM1 Q05193 1/20 0.39
BCHE P06276 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
ALDH1A1 P00352 4/20 0.37
PHLPP2 Q6ZVD8 1/20 0.37
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL3785079 1.00 THRB (0.47) THRBCHRM2CHRM4CHRM5CHRM1
SCHEMBL19547980 0.95 THRB (0.46) THRBCHRM2CHRM4CHRM5CHRM1
SCHEMBL28520553 0.93 THRB (0.49) THRBCHRM2CHRM4CHRM5CHRM1
SCHEMBL28671752 0.92 CHRM2 (0.54) THRBCHRM2CHRM4CHRM5CHRM1
SCHEMBL14984 0.92 CHRM2 (0.54) THRBCHRM2CHRM4CHRM5CHRM1
SCHEMBL29221412 0.91 THRB (0.43) THRBCHRM2CHRM4CHRM5CHRM1
SCHEMBL127614 0.91 THRB (0.43) THRBCHRM2CHRM4CHRM5CHRM1
Fluoride SCHEMBL1255040 0.90 CHRM2 (0.52) THRBCHRM2CHRM4CHRM5CHRM1
Bromide SCHEMBL1255341 0.90 CHRM2 (0.52) THRBCHRM2CHRM4CHRM5CHRM1
Ammonia Solution, Strong SCHEMBL8139148 0.90 CHRM2 (0.52) THRBCHRM2CHRM4CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 818 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070397-A Use of fast reverse cationic emulsion polymers with polyvinylamines as retention and drainage aids 凯米拉公司 2026-05-19 CN claimed
EP-4739418-A2 ONE-PASS DEOXYGENATION METHOD FOR POLYACRYLAMIDE PRODUCTION KEMIRA OYJ (FI) 2026-05-13 EP claimed
EP-4728136-A1 STRENGTH SYNERGY BETWEEN POLYMER AND PAPERMAKING STRENGTH AID Ecolab USA, Inc. (US) 2026-04-22 EP claimed
EP-4716777-A2 USE OF AMPHOTERIC EMULSION POLYMERS WITH STRENGTH RESINS AS RETENTION AND DRAINAGE AIDS KEMIRA OYJ (FI) 2026-04-01 EP claimed
US-12553188-B2 GPAM compositions and methods KEMIRA OYJ (FI) 2026-02-17 US claimed
EP-4683950-A1 DUAL EMULSIFICATION OF ALKENYL SUCCINIC ANHYDRIDE TO IMPROVE SIZING PERFORMANCE AND STABILITY KEMIRA OYJ (FI) 2026-01-28 EP claimed
US-20250215649-A1 HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYSACCHARIDE PROMOTER KEMIRA OYJ (FI) 2025-07-03 US claimed
CN-115516031-B GPAM compositions and methods 凯米拉公司 2025-06-17 CN claimed
US-20250137200-A1 HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYMERIC PROMOTER KEMIRA OYJ (FI) 2025-05-01 US claimed
EP-4256009-B1 OIL-IN-WATER EMULSIONS QUADRISE INT LTD (GB) 2025-04-09 EP claimed
US-6344531-B1 Fluorescent water-soluble polymers NALCO CHEMICAL COMPANY 2002-02-05 US claimed
WO-2001081654-A1 FLUORESCENT MONOMERS AND TAGGED TREATMENT POLYMERS CONTAINING SAME FOR USE IN INDUSTRIAL WATER SYSTEMS ONDEO NALCO COMPANY (US) 2001-11-01 WO claimed
US-6177017-B1 COMPLEXING WITH 1,4-DIAZABICYCLO(2.2.2) OCTANE POLYMERS NALCO CHEMICAL COMPANY 2001-01-23 US claimed
US-6114484-A REMOVAL OF METAL CYANIDES OR OXOANIONS FROM AQUEOUS STREAMS SUCH AS WASTE WATER STREAMS WITH COMPOUNDS CONTAINING 1,4-DIAZABICYCLO(2.2.2)OCTANE NALCO CHEMICAL COMPANY (US) 2000-09-05 US claimed
EP-0984990-A1 PREPARATION OF WATER SOLUBLE POLYMER DISPERSIONS FROM VINYLAMIDE MONOMERS NALCO CHEMICAL COMPANY (US) 2000-03-15 EP claimed
EP-0970258-A1 POLYMERIC COMBINATIONS USED AS COPPER AND PRECIOUS METAL HEAP LEACHING AGGLOMERATION AIDS NALCO CHEMICAL COMPANY (US) 2000-01-12 EP claimed
WO-1999020803-A1 POLYMERIC COMBINATIONS USED AS COPPER AND PRECIOUS METAL HEAP LEACHING AGGLOMERATION AIDS NALCO CHEMICAL COMPANY (US) 1999-04-29 WO claimed
WO-1998054234-A1 PREPARATION OF WATER SOLUBLE POLYMER DISPERSIONS FROM VINYLAMIDE MONOMERS NALCO CHEMICAL COMPANY (US) 1998-12-03 WO claimed
US-5833937-A AGGLOMERATING BY SEQUENTIAL ADDITION OF FIRST WATER SOLUBLE ANIONIC OR NONIONIC POLYMER AND SECOND CATIONIC WATER SOLUBLE POLYMER NALCO CHEMICAL COMPANY (US) 1998-11-10 US claimed
US-4190717-A BULK POLYMERIZATION OT PRODUCE WATER-SOLUBILE CATIONIC POLYMER IN FORM OF LUMP NITTO CHEMICAL INDUSTRY CO., LTD. (JP) 1980-02-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12553188-B2 GPAM compositions and methods PGM2, SLC6A9, GNMT CHRM2 680/4885CHRM1 848/4885CHRM3 1722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.